PRTA
Prothena Corporation PLC
Price:  
10.50 
USD
Volume:  
319,029.00
Ireland | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PRTA EV/EBITDA

-415.9%
Upside

As of 2026-04-13, the EV/EBITDA ratio of Prothena Corporation PLC (PRTA) is -1.40. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRTA's latest enterprise value is 257.68 mil USD. PRTA's TTM EBITDA according to its financial statements is -183.99 mil USD. Dividing these 2 quantities gives us the above PRTA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 7.5x - 15.4x 11.5x
Forward P/E multiples 8.4x - 14.2x 11.3x
Fair Price (23.07) - (42.75) (33.17)
Upside -319.7% - -507.2% -415.9%
10.50 USD
Stock Price
(33.17) USD
Fair Price

PRTA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-04-10 -1.39
2026-04-09 -1.42
2026-04-08 -1.44
2026-04-07 -1.36
2026-04-06 -1.27
2026-04-02 -1.21
2026-04-01 -1.26
2026-03-31 -1.17
2026-03-30 -1.03
2026-03-27 -1.04
2026-03-26 -1.11
2026-03-25 -1.05
2026-03-24 -0.88
2026-03-23 -0.91
2026-03-20 -0.89
2026-03-19 -0.83
2026-03-18 -0.84
2026-03-17 -0.96
2026-03-16 -1.01
2026-03-13 -1.02
2026-03-12 -1.05
2026-03-11 -1.13
2026-03-10 -1.19
2026-03-09 -1.20
2026-03-06 -1.13
2026-03-05 -1.10
2026-03-04 -1.21
2026-03-03 -1.07
2026-03-02 -1.08
2026-02-27 -0.87
2026-02-26 -0.86
2026-02-25 -0.93
2026-02-24 -0.95
2026-02-23 -0.98
2026-02-20 -0.97
2026-02-19 -0.97
2026-02-18 -0.99
2026-02-17 -0.95
2026-02-13 -0.95
2026-02-12 -0.92
2026-02-11 -0.94
2026-02-10 -0.95
2026-02-09 -0.92
2026-02-06 -0.94
2026-02-05 -0.77
2026-02-04 -0.93
2026-02-03 -0.90
2026-02-02 -0.94
2026-01-30 -0.91
2026-01-29 -0.98